维普中文期刊产品整合服务
25篇 您的检索式:作者名="Cancarini"
    题名 作者 年代 出处 被引量
1A six-year comparison of patient and technique survivals in CAPD and HD显示文摘 Vonesh E Cancarini GC 1988Kidney Int1988,34,4:1
2Pharmacokinetic and pharmacodynamic properties of anti-VEGF drugs after intra- vitreal iiyection 显示文摘SEMERARO F MORESCALCHI F DUSE S GAMBICORTI E CANCARINI A COSTAGLIOLA C 2015Curr Drug Metab2015,16,7:1
3Predicting the risk of diabetic retinopathy in type 2diabetic patients显示文摘Semeraro F Parrinello G Cancarini A 2011Journal of Diabetes and its Complications2011,25,5:1
4Ten years experience of CAPD in diabetics:comparison of results with no-ndiabetics显示文摘Viglino G Cancarini GC Catizone L 1994Nephrol Dial Transplant1994,9,10:1
5Predicting the risk of diabetic retinopathy in type 2 diabetic patients 显示文摘Semeraro F Parrinello G Cancarini A 2011Journal of Diabetes and its Complications2011,25,5:1
6Serum and intraocu- lar concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy 显示文摘Semeraro F Cancarini A Morescalchi F 2014Diabetes Metab2014,40,6:1
7Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study显示文摘Gian Marco Ghiggeri Paolo Catarsi Francesco Scolari Gianluca Caridi Roberta Bertelli Alba Carrea Simone Sanna-Cherchi Francesco Emma Landino Allegri Giovanni Cancarini Gian Franco Rizzoni Francesco Perfumo 2004Clinical Therapeutics2004,,9:1
8Pro And Anti-Inflammatory Cytokine Gene Expression In Subcutaneous And Visceral Fat In Severe Obesity显示文摘B. Spoto E. Di Betta F. Mattace-Raso E. Sijbrands A. Vilardi R.M. Parlongo P. Pizzini A. Pisano W. Vermi A. Testa S. Cutrupi G. D’Arrigo S. Lonardi G. Tripepi G. Cancarini C. Zoccali 2014Nutrition Metabolism and Cardiovascular Diseases2014,,:1
9Which treatment for which patient in the future?Possible modifications in CAPD显示文摘Maiorca R Cancarini G Brunori G Zubani R Camerini C Manili L 0,,7:1
10Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membrancs in haemodialysis patients显示文摘Movilli E Cancarini GC Zani R 2001Nephrol Dial Transplant2001,16,1:1
11Diabetic Retinopathy: Vascular and Inflammatory Disease显示文摘Semeraro F Cancarini A dell'Omo R 2015J Diabetes Res2015,2015,58:1
12The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients显示文摘Cassamali S Scolari F Cancarini GC 2006Blood Purif2006,24,4:1
13Predicting the risk of diabetic retinopathy in type 2diabetic patients显示文摘Semeraro F Parrinello G Cancarini A 2011Journal of Diabetes and its Complications2011,25,5:1
14Adequacy ofdialysis reduces the doses of recombinant erythropoietinindependently from the use of biocompatible membranes inhaemodialysis patients 显示文摘MOVILLI E CANCARINI GC ZANI R 2001Nephrol Dial Transplant2001,16,1:1
15Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haenodialysis patients显示文摘MOVILLI E CANCARINI G C ZANI R 2001Nephrol Dial Transplant2001,16,1:1
16Long-teIm peritoneal dialysis out- come in a single center 显示文摘Cancarini GC Sandrini M 2000Perit Dial Int2000,20,2:1
17Diabetic Reti- nopathy: Vascular and Inflammatory Disease显示文摘Semeraro F Cancarini A dell'Omo R 2015J Diabetes Res2015,116,:1
18Serum and intraoeu- lar concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy 显示文摘Semeraro F Cancarini A Morescalchi F 2014Diabetes Metab2014,40,6:1
19Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythro- poietin in patients with proliferative diabetic retinopathy 显示文摘Cancarini A Costagliola C Dell'omo R 2014Minerva Endocrlnol2014,39,4:1
20Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients显示文摘MOVILLI E CANCARINI G C ZANI R 2001Nephrol Dial Transplant2001,16,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费